HDAC9 and cancer: In addition to cancer therapeutics, the successful use of HDAC inhibitors to target epigenetic dysregulation in psychiatric disorders and findings that HDAC inhibitors can function as potent anti-inflammatory agents have recently sparked much intrigue as to the possibility of using HDAC inhibitors to treat or even prevent neurodegenerative disorders as well.